TISCH MULTIPLE SCLEROSIS RESEARCH … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

AMANDA B OPPENHEIMER

Phone

6465573900

Tax Period

2025-01-01 to 2025-12-31

TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK INC, founded in 2005, is a community nonprofit in the Medical Research sector that reported $9.5M in total revenue in fiscal year 2025. Revenue decreased 8% compared to the prior year.

Mission

THE PURPOSE OF TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NY, INC. IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD FINDING THE CAUSE AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS.

Program Service Accomplishments

Program 1

Expenses: $7,540,138 Revenue: $9,518,725

TISCH MS RESEARCH CENTER OF NEW YORK'S (TISCH MSRCNY) MISSION IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD DISCOVERING THE CAUSE OF AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. THESE RESEARCH...

TISCH MS RESEARCH CENTER OF NEW YORK'S (TISCH MSRCNY) MISSION IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD DISCOVERING THE CAUSE OF AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. THESE RESEARCH INITIATIVES INCLUDE: TO BETTER UNDERSTAND AND TREAT COORDINATION AND BALANCE DIFFICULTIES IN PATIENTS WITH MS. TO CREATE AN EXPERIMENTAL MODEL OF PROGRESSIVE MS THAT WILL ENABLE US TO BETTER UNDERSTAND AND TREAT PATIENTS WITH SECONDARY PROGRESSIVE MS (SPMS) AND PRIMARY PROGRESSIVE MS (PPMS). TO UTILIZE NOVEL CEREBROSPINAL FLUID BASED ANIMAL MODELS TO BETTER UNDERSTAND OTHER NEURODEGENERATIVE DISEASES SUCH AS MS AND ALS. TO DEVELOP ORGANOID MODELS TO BETTER UNDERSTAND THE UNDERPINNINGS OF PROGRESSIVE MS. FINALLY, AND PERHAPS MOST IMPORTANTLY, TO IDENTIFY THE INITIAL TRIGGER(S) THAT CAUSE MS. IN 2025, DRS WONG AND SADIQ PUBLISHED RESULTS FROM A COLLABORATION WITH NEURON23, INC. IN THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. THE STUDY USED THE PPMS ANIMAL MODEL DEVELOPED AT TISCH MS TO DEMONSTRATE PROOF OF CONCEPT OF A NOVEL MS THERAPEUTIC. IN 2025, TISCH MSRCNY RESEARCHERS WERE INVITED TO PRESENT RESEARCH ABSTRACTS AT THE ANNUAL CONFERENCES OF ACTRIMS (AMERICAS COMMITTEE FOR TREATMENT AND RESEARCH IN MS), THE AMERICAN ADADEMY OF NEUROLOGY AND THE SOCIETY FOR NEUROSCIENCE.

Program 2

Expenses: $6,672

AS AN ACADEMIC FACILITY, THE TISCH MS RESEARCH CENTER PROVIDES EDUCATIONAL AND TRAINING RESOURCES FOR MS RESEARCHERS AND MEDICAL PROFESSIONALS. ONE OF THE MOST IMPORTANT GOALS OF TISCH MSRCNY IS TO PROVIDE RESEARCH OPPORTUNITIES FOR YOUNG SCIENCE GRADUATES THAT ENABLE THEM TO BECOME CAREER SCIENTISTS. SINCE ITS INCEPTION, THEY HAVE TRAINED OVER 100 COLLEGE GRADUATES AS RESEARCH ASSISTANTS (RAS) FOR 2-YEAR ROTATIONS. IN 2025, ALL SECOND YEAR RESEARCH ASSISTANTS, UNDER THE GUIDANCE OF TISCH MSRCNY PRINCIPAL INVESTIGATORS, MATRICULATED TO TOP MEDICAL SCHOOLS AND GRADUATE PROGRAMS. FELLOWSHIPS IN MS RESEARCH ARE ALSO OFFERED TO PHYSICIANS AND SCIENTISTS INTERESTED IN ENTERING OR EXPANDING THEIR WORK IN THIS FIELD. WEEKLY JOURNAL CLUB MEETINGS OR GRAND ROUNDS TAKE PLACE IN OUR CONFERENCE ROOM TO DISCUSS THE LATEST ADVANCEMENTS IN MS RESEARCH AND HOW IT APPLIES TO OUR CURRENT INVESTIGATIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $5,829,026

Program Service Revenue $31,939

Investment Income $-6,780

Other Revenue $3,657,760

TOTAL REVENUE $9,511,945

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,273,559

Fundraising Expenses $747,765

Program Expenses $7,546,810

Other Expenses $6,147,484

TOTAL EXPENSES $9,421,043

Year-over-Year Comparison

	2025	2024	Change
Revenue	$9,511,945	$10,372,263	-0.1%
Expenses	$9,421,043	$10,688,042	-0.1%
Net Income	$90,902	$-315,779	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$191,920

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PHILIP WEISBERG	CHAIR	5.00	Officer Director	$0	$0	$0
PHILIP R PELLER	AUDIT COMMITTEE CHAIR	2.00	Director	$0	$0	$0
BERNADETTE MARIANI	NOMINATING COMMITTEE CHAIR	2.00	Director	$0	$0	$0
WILLIAM M DRUMMY JR	DEVELOPMENT COMMITTEE CHAIR	2.00	Director	$0	$0	$0
SAUD A SADIQ MD	DIRECTOR/CHIEF RESEARCH SCIENTIST	15.00	Officer Director	$0	$0	$0
LEE J SEIDLER	CHAIRMAN EMERITUS	0.50		$0	$0	$0
AMANDA B OPPENHEIMER	CHIEF OPERATING OFFICER	40.00	Officer	$177,186	$14,734	$191,920
CLIFFORD EISLER	TREASURER	2.00	Officer Director	$0	$0	$0
SHARYL REISMAN	SECRETARY	2.00	Officer Director	$0	$0	$0
TALENE KELLY	DIRECTOR OF DEVELOPMENT	40.00	Highest	$145,206	$5,589	$150,795
JAMES CONNELL	DIRECTOR	0.50	Director	$0	$0	$0
MANNY SCHNAIDMAN	DIRECTOR	0.50	Director	$0	$0	$0
ALAN TISCH	DIRECTOR	0.50	Director	$0	$0	$0
THOMAS R MAYER	DIRECTOR	0.50	Director	$0	$0	$0
MUSA MAYER	DIRECTOR	0.50	Director	$0	$0	$0
PAUL PURCELL	DIRECTOR	0.50	Director	$0	$0	$0
PHILIP J PURCELL	DIRECTOR	0.50	Director	$0	$0	$0
ALLA WEISBERG	DIRECTOR	0.50	Director	$0	$0	$0
DANIEL TISCH	DIRECTOR	0.50	Director	$0	$0	$0
BONNIE TISCH	DIRECTOR	0.50	Director	$0	$0	$0
RICHARD SCHWARTZ	DIRECTOR	0.50	Director	$0	$0	$0
GRETA RUBIN SCHWARTZ	DIRECTOR	0.50	Director	$0	$0	$0
MONIKA PAREKH	DIRECTOR	0.50	Director	$0	$0	$0
DEVEN PAREKH	DIRECTOR	0.50	Director	$0	$0	$0
ELIZABETH MASLOW MONTESANO	DIRECTOR	0.50	Director	$0	$0	$0
JAMES MARIANI	DIRECTOR	0.50	Director	$0	$0	$0
PAUL LATTANZIO	DIRECTOR	0.50	Director	$0	$0	$0
CHARLES THOELE	DIRECTOR	0.50	Director	$0	$0	$0
BRADLEY H FRIEDRICH	DIRECTOR	0.50	Director	$0	$0	$0
BONNIE EISLER	DIRECTOR	0.50	Director	$0	$0	$0
CYNTHIA D BRODSKY	DIRECTOR	0.50	Director	$0	$0	$0
ENKE BASHLLARI PHD	DIRECTOR	0.50	Director	$0	$0	$0
HILLARY MANDEL	DIRECTOR	0.50	Director	$0	$0	$0
VIOLAINE HARRIS	SENIOR RESEARCH SCIENTIST	40.00	Highest	$255,540	$16,563	$272,103
JERRY LIN	SENIOR STAFF ASSOCIATE	40.00	Highest	$135,882	$10,951	$146,833
JAMIE WONG	RESEARCH SCIENTIST	40.00	Highest	$148,790	$11,887	$160,677

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$9,511,945	$9,421,043	$27,670,515	$90,902
2024	$10,372,263	$10,688,042	$29,507,214	$-315,779
2023	$11,745,150	$10,398,811	$32,159,816	$1,346,339
2022	$10,932,221	$9,428,826	$34,331,783	$1,503,395
2021	$12,621,293	$9,924,324	$14,119,730	$2,696,969
2020	$9,907,101	$10,064,420	$11,089,432	$-157,319
2019	$11,719,033	$9,425,896	$10,880,866	$2,293,137

TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK INC